Cryptopolitan
2025-08-05 11:10:52

Core Scientific investors expected to resist CoreWeave’s merger bid

Core Scientific shareholders are reportedly pushing back against CoreWeave’s terms in its proposed acquisition of the company. They argued that the $9 billion deal undervalues the company and would leave them short-changed. The Financial Times reported Tuesday, citing people familiar with the matter, that some of the shareholders want to vote against the acquisition unless there are future changes in the terms. The report revealed that the shareholders’ vote for the deal has not been scheduled but is expected to take place this fall. CORZ aims to maximize shareholder value Former Attorney General of Louisiana Charles Foti and the law firm of Khan Swick & Foti also opened investigations last month into the acquisition. The law firm said it wanted to determine whether the proposed 0.1235 shares of CoreWeave stock to be issued to CORZ shareholders were adequate or undervalued the company. According to CoreWeave’s $9 billion acquisition valuation, the deal represented $20.40 per share value based on the company’s stock closing price as of July 3, 2025. The company estimated that the deal would result in shareholders’ ownership being less than 10%. The FT report didn’t specify which terms the shareholders sought to amend. According to the GPU cloud firm, some financial impacts of the acquisition include removing over $10 billion of cumulative future lease payments for existing contractual sites. The firm also seeks to add another $500 of estimated annual rate cost savings by the end of 2027. Core Scientific CEO Adam Sullivan believes the agreement will help the firm advance its AI infrastructure for companies while maximizing shareholder value. The company also said the acquisition will help CoreWeave establish its data center network to ensure long-term revenue growth and boost profitability. “Verticalizing the ownership of Core Scientific’s high-performance data center infrastructure enables CoreWeave to significantly enhance operating efficiency and de-risk our future expansion, solidifying our growth trajectory.” – Michael Intrator , CEO and Co-founder of CoreWeave. CoreWeave had previously offered to acquire Core Scientific in 2024, but the bid was rejected for being too low. The company’s proposed $5.75 per share valued the Bitcoin miner at just $1 billion. Core Scientific later proposed a $1.225 billion agreement to enhance infrastructure support for its Nvidia chips and also deepen its existing relationship with CoreWeave. CORZ acknowledged that it aims to provide 70 megawatts of infrastructure in the Bitcoin company’s facilities in Austin, Texas, in the second half of 2025. The cloud computing provider would fund the necessary capital investments worth around $3.5 billion over its 12-year term. Core Scientific advances its crypto mining capacity Core Scientific reported $580 million in growth in the first quarter of the year. The firm’s revenue dropped slightly to $79.5 million, attributed to the April 2024 quadrennial halving, which reduced BTC’s mining rewards to 3.125 BTC from 6.25 BTC. Core Scientific’s Q1 revenue came from $67.2 million in self-mining revenue, $3.8 million in hosted mining revenue, and $8.6 million in HPC hosting. The firm estimates an annualized colocation revenue of roughly $360 million entering 2026. Sullivan said the company intends to transform and expand its crypto mining capacity and earning power. The company also hopes to deliver 250 MW of mining capacity to the Bitcoin company by the end of this year. At the time of publication, Core Scientific holds 977 BTC and ranks 38th among companies holding Bitcoin. The company’s stock price is also exchanging hands at $13.65, an 8% increase in the last 24 hours. Want your project in front of crypto’s top minds? Feature it in our next industry report, where data meets impact.

获取加密通讯
阅读免责声明 : 此处提供的所有内容我们的网站,超链接网站,相关应用程序,论坛,博客,社交媒体帐户和其他平台(“网站”)仅供您提供一般信息,从第三方采购。 我们不对与我们的内容有任何形式的保证,包括但不限于准确性和更新性。 我们提供的内容中没有任何内容构成财务建议,法律建议或任何其他形式的建议,以满足您对任何目的的特定依赖。 任何使用或依赖我们的内容完全由您自行承担风险和自由裁量权。 在依赖它们之前,您应该进行自己的研究,审查,分析和验证我们的内容。 交易是一项高风险的活动,可能导致重大损失,因此请在做出任何决定之前咨询您的财务顾问。 我们网站上的任何内容均不构成招揽或要约